ADICET BIO INC's ticker is ACET and the CUSIP is 007002108. A total of 91 filers reported holding ADICET BIO INC in Q1 2022. The put-call ratio across all filers is 1.13 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,755 | -43.5% | 2,741 | 0.0% | 0.00% | – |
| Q2 2023 | $6,647 | -69.0% | 2,741 | -26.3% | 0.00% | – |
| Q1 2023 | $21,410 | -69.3% | 3,717 | -52.3% | 0.00% | – |
| Q4 2022 | $69,669 | -33.0% | 7,793 | +6.8% | 0.00% | – |
| Q3 2022 | $104,000 | +11.8% | 7,297 | +14.8% | 0.00% | – |
| Q2 2022 | $93,000 | +121.4% | 6,358 | +204.5% | 0.00% | – |
| Q1 2022 | $42,000 | +44.8% | 2,088 | +25.3% | 0.00% | – |
| Q4 2021 | $29,000 | +123.1% | 1,666 | 0.0% | 0.00% | – |
| Q3 2021 | $13,000 | -23.5% | 1,666 | 0.0% | 0.00% | – |
| Q2 2021 | $17,000 | – | 1,666 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 728,944 | $998,653 | 0.37% |
| DAFNA Capital Management LLC | 797,054 | $1,091,964 | 0.34% |
| COWEN AND COMPANY, LLC | 2,715,278 | $3,719,930 | 0.26% |
| Orbimed Advisors | 8,322,140 | $11,401,332 | 0.24% |
| TANG CAPITAL MANAGEMENT LLC | 1,226,352 | $1,680,102 | 0.24% |
| Carlyle Group Inc. | 2,115,385 | $2,876,924 | 0.12% |
| RTW INVESTMENTS, LP | 4,241,472 | $5,810,817 | 0.12% |
| Acuitas Investments, LLC | 136,779 | $187,387 | 0.11% |
| Decheng Capital Management III (Cayman), LLC | 200,201 | $274,275 | 0.09% |
| GSA CAPITAL PARTNERS LLP | 142,168 | $195 | 0.02% |